Compugen Ltd (CGEN) FinancialsCGENCompugen Ltd

Evaluating the bottom line, Compugen Ltd. maintains a gross margin of -3.54%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -339.62%, while the net margin is -269.25%. These profitability ratios, combined with a Return on Equity (ROE) of 50.64%, provide a clear picture of how effectively CGEN converts its operational activities into shareholder value.

In the context of the broader market, CGEN competes directly with industry leaders such as UPB and ZNTL. With a market capitalization of $192.30M, it holds a significant position in the sector. When comparing efficiency, CGEN's gross margin of -3.54% stands against UPB's 100.00% and ZNTL's N/A. Such benchmarking helps identify whether Compugen Ltd. is trading at a premium or discount relative to its financial performance.

Compugen's financial performance shows a significant revenue surge in Q4 2025 with $67.33 million, but it faced losses in subsequent quarters, including a net income loss of $7.67 million in Q1 2026. The gross margin is highly variable, with a peak of 94.75% in Q4 2025, but dropping to -3.54% in Q2 2026.